Company Filing History:
Years Active: 2022
Title: Kristin N Heller: Innovator in Muscular Dystrophy Research
Introduction
Kristin N Heller is a prominent inventor based in Columbus, OH (US). She has made significant contributions to the field of gene therapy, particularly in the treatment of muscular dystrophy. With a total of 2 patents, her work focuses on innovative methods to address the challenges associated with this debilitating condition.
Latest Patents
Heller's latest patents include groundbreaking inventions aimed at improving treatment options for muscular dystrophy. One of her notable patents is titled "Adeno-associated virus vector delivery of microRNA-29 and micro-dystrophin to treat muscular dystrophy." This invention provides recombinant AAV vectors that comprise a polynucleotide sequence containing the guide strand of miR-29c. The methods outlined in this patent aim to reduce or prevent fibrosis in subjects suffering from dystrophinopathy or muscular dystrophy. Additionally, it offers combination therapies that express both miR-29 and micro-dystrophin to further mitigate fibrosis in affected patients.
Another significant patent is "Adeno-associated virus vector delivery of microRNA-29 to treat muscular dystrophy." Similar to her previous work, this invention also provides recombinant AAV vectors with a polynucleotide sequence comprising the guide strand of miR-29c. The methods described are designed to reduce or prevent fibrosis in individuals suffering from muscular dystrophy.
Career Highlights
Heller is affiliated with the Research Institute at Nationwide Children's Hospital, where she conducts her research. Her work is characterized by a commitment to advancing therapeutic strategies for muscular dystrophy, showcasing her dedication to improving patient outcomes.
Collaborations
Throughout her career, Heller has collaborated with esteemed colleagues, including Louise Rodino-Klapac and Jerry R Mendell. These partnerships have enhanced her research efforts and contributed to the development of innovative therapies.
Conclusion
Kristin N Heller is a trailblazer in the field of muscular dystrophy research, with her patents reflecting her innovative approach to treatment. Her contributions are paving the way for new therapeutic options that hold promise for patients suffering from this challenging condition.